CHF: Congestive Heart Failure Pilot Study Utilizing Wireless Home Scale and Daily Symptom Monitoring

Sponsor

University of Pennsylvania (Other)

Overall Status

Completed

CT.gov ID

NCT03234088

Collaborator

(none)

Enrollment

Location

Arm

Duration (Months)

0.8

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

As the population ages and medicine advances, there has been a significant shift to the management of chronic diseases. Most chronic diseases are managed using evidence based consensus guidelines but clinician and patient compliance with these guidelines is sub-optimal. In addition, due to the nature of chronic diseases, patients need to make long-term lifestyle changes in order to effectively control their disease in order to minimize complications, disability and cost. It is these two factors, consistent implementation of evidence-based guidelines and supporting patients in a way that encourages self-management and lifestyle change, that disease management attempts to impact. There are areas of design, implementation, testing and final-result-reporting to the patient and clinician that require collaboration among information technology (IT) and software design engineers and clinicians to achieve several goals:

Ensure patient safety.
Protect the security and integrity of clinical data.
Provide patient specific education to promote self-management.
Provide actionable data to clinicians in order to improve clinical care and minimize the risk of adverse events.
Provide both patient and clinician satisfaction with the system of care.

In order to achieve these goals, testing and development of home technology under a controlled clinical trial is critical.

Condition or Disease	Intervention/Treatment	Phase
Congestive Heart Failure	Behavioral: Daily weight measured by digital scale and symptom reporting	N/A

Detailed Description

This study will consist of: Specific Aim 1, Perform a pilot study to evaluate the initial performance of the wireless scale and symptom monitoring system on a select number of presumed normal volunteers (five). The purpose of this will be to determine design and process changes prior to the use of the device in subjects with chronic heart failure (HF). The investigators will have each normal volunteer (all part of the key research team) perform scenarios to test the performance of the system. Specific Aim 2 will incorporate changes into the prototype system adapting both the technology as well as the clinical workflows surrounding its use based on the information collected in Specific Aim 1. Specific Aim 3 will evaluate the revised system enrolling 40 volunteer subjects that have provided written voluntary consent with the documented primary diagnosis of HF (systolic or diastolic) to participate in the intervention over a 4-month period with the primary outcome measure being reduction in HF related ER visit or hospitalization.

The objective of this study is to pilot test and refine a new home-based telemedicine health monitoring system that provides wireless, low cost measurement of body weight as well as self-reported responses, including symptoms and medication compliance for the purpose of managing chronic heart failure (HF) within the home. This pilot will test the functionality of the research infrastructure first on 5 healthy volunteers and then on 40 patients with heart failure over 4 months, testing the receipt of accurate input from the wireless scale and then assessing the effectiveness of the scale intervention in reducing ER visits and hospitalizations.

Study Design

Study Type:

Interventional

Actual Enrollment :

13 participants

Allocation:

N/A

Intervention Model:

Single Group Assignment

Masking:

None (Open Label)

Primary Purpose:

Health Services Research

Official Title:

Home Based Health Monitoring for Congestive Heart Failure Pilot

Study Start Date :

Apr 1, 2011

Actual Primary Completion Date :

Aug 1, 2011

Actual Study Completion Date :

Aug 1, 2012

Arms and Interventions

Arm	Intervention/Treatment
Other: Home HF monitoring Digital scale readings are transmitted wirelessly to the handheld device. Patients will remotely log on to a secure server to answer daily symptom questions. Patients will complete surveys after voluntarily completing the informed consent process and at study closeout.	Behavioral: Daily weight measured by digital scale and symptom reporting All subjects will be provided the intervention. Other Names: MedApps Healthcom wireless digital scale is being utilized

Arm

Intervention/Treatment

Other: Home HF monitoring

Digital scale readings are transmitted wirelessly to the handheld device. Patients will remotely log on to a secure server to answer daily symptom questions. Patients will complete surveys after voluntarily completing the informed consent process and at study closeout.

Behavioral: Daily weight measured by digital scale and symptom reporting

All subjects will be provided the intervention.

Other Names:

MedApps Healthcom wireless digital scale is being utilized

Outcome Measures

Primary Outcome Measures

Usage of home-health monitoring devices for weight [Baseline through study completion, an average of four months]
Monitoring daily weights and heart failure symptoms

Secondary Outcome Measures

Patient and Provider Questionnaires on usability and functionality of the study's online web portal (Way to Health) [Baseline through study completion, an average of four months]
Patient and Provider Questionnaires on usability and functionality of the study's wifi-enabled home health monitoring devices [Baseline through study completion, an average of four months]

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Primary diagnosis of heart failure (either systolic or diastolic) NYHA class II, III and IV
Physical and cognitive ability to use the device
Cellular phone or other portable device with "text" communication capability or daily access to the internet using a computer or laptop

Exclusion Criteria:

Subject with life expectancy less than 6 months from any cause, or enrolled in hospice care.
Subject not competent or unwilling to give voluntary informed consent.
Subject currently participating in another home telemedicine intervention trial
Subjects with a left ventricular assist device or who have had a cardiac transplant
Dialysis upon screening or creatinine >2.5